KV may resume shipments in the fourth quarter
09 September 2009
Nancy Faigen
Please Login to read the full article.
09 September 2009
Nancy Faigen
nancy.faigen@informausa.com
KV Pharmaceutical says that the US FDA has accepted the company's work plan that aims to address previously identified deficiencies in current good manufacturing practice (cGMP) and product distribution.
In a September 2nd 8-K filing with the US Securities and Exchange...
Please Login to read the full article.
RELATED CONTENT
NEWS
- KV jumps 119% on FDA probe of competing compounded preterm birth drug
- Drugs from Ranbaxy India plants banned from US until fixes confirmed
- Market chops 21% off head-in sand Hospira as it slashes its 2011 revenue forecast
- US Capitol Capsule: US health officials reflect on 30 years of HIV/AIDS
COMMENT
Other Informa Comment
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
